DISPATCHES FROM INTERPHEX

New DFS Unit Built on Technology, R&D and Manufacturing, says Capsugel

By Dan Stanton

- Last updated on GMT

Related tags: Dosage forms

Following a busy few months, Capsugel spoke about the formation of its Dosage Form Solutions Unit, its technology and the integration of Encap at this year's Interphex in New York.

According to Aresh Tahbez, the Director of Global Marketing at Capsugel’s recently formed Dosage Forms Solutions (DFS) Unit, the Unit is built upon three areas: Capsugel’s technologies, its R&D capabilities and its manufacturing infrastructure.

He also told us that Encap – acquired in March this year​ - was being integrated well and was “providing Capsugel DFS with a leadership position in liquid-filled hard capsules.”

Capsugel was also showcasing its CFS1200 liquid-filling and sealing machine which can be used for clinical batches or upscaled for larger manufacturing scales, and can be seen in action in the video above.

Related news

Show more

Related products

show more

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Related suppliers

Follow us

Products

View more

Webinars